FDA Adverse Event Injury Summary report: N

SELF CENT HIP 52X28 BLU

MDR report key: 3933018 · Received July 14, 2014

Report

Report Number
1818910-2014-23296
Event Type
Injury
Date Received
July 14, 2014
Date of Event
August 17, 2013
Report Date
June 27, 2014
Manufacturer
DEPUY ORTHOPAEDICS, INC.
Product Code
KWY
PMA / PMN Number
PK812672
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

THE DEVICES ASSOCIATED WITH THIS REPORT WERE NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATIONS. MEDICAL RECORDS WERE OBTAINED AND REVIEWED BY A MEDICAL PROFESSIONAL. WITH THE INFORMATION PROVIDED, IT IS DETERMINED THE PATIENT¿S COMPLAINT OF PAIN IS NOT PRODUCT RELATED, BUT RATHER TO DEGENERATION OF HIS ACETABULAR CARTILAGE FOLLOWING THE ORIGINAL SURGERY. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Additional Manufacturer Narrative · 1

THE RETURNED DEVICES WERE EXAMINED BY DEPUY RESEARCH. NO PRODUCT PROBLEM WAS IDENTIFIED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER RELATED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATIONS. MEDICAL RECORDS AND X-RAYS WERE OBTAINED AND REVIEWED BY A MEDICAL PROFESSIONAL. WITH THE INFORMATION PROVIDED, IT IS DETERMINED THE PATIENT¿S COMPLAINT OF PAIN IS NOT PRODUCT RELATED, BUT RATHER TO DEGENERATION OF HIS ACETABULAR CARTILAGE FOLLOWING THE ORIGINAL SURGERY. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED. DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

THE DEVICE ASSOCIATED WITH THIS REPORT WAS NOT RETURNED. A COMPLAINT DATABASE SEARCH FINDS NO OTHER REPORTED INCIDENTS AGAINST THE PROVIDED PRODUCT AND LOT COMBINATION. MEDICAL RECORDS WERE OBTAINED AND REVIEWED BY A MEDICAL PROFESSIONAL. WITH THE INFORMATION PROVIDED, IT IS DETERMINED THE PATIENT¿S COMPLAINT OF PAIN IS NOT PRODUCT RELATED, BUT RATHER TO DEGENERATION OF HIS ACETABULAR CARTILAGE FOLLOWING THE ORIGINAL SURGERY. THE INVESTIGATION COULD NOT VERIFY OR IDENTIFY ANY PRODUCT CONTRIBUTION TO THE REPORTED EVENT WITH THE INFORMATION PROVIDED. BASED ON THE INABILITY TO IDENTIFY ROOT CAUSE, THE NEED FOR CORRECTIVE ACTION WAS NOT INDICATED.DEPUY CONSIDERS THE INVESTIGATION CLOSED. SHOULD ADDITIONAL INFORMATION BE RECEIVED, THE INFORMATION WILL BE REVIEWED AND THE INVESTIGATION WILL BE RE-OPENED AS NECESSARY.

Description of Event or Problem · 1

LITIGATION ALLEGES THE PATIENT SUFFERS FROM DIFFICULTIES, A FAILED HIP IMPLANT AND PAIN. UPDATE REC'D (B)(4) 2014- PFS AND MEDICAL RECORDS RECEIVED. PART/LOT WAS PROVIDED. AFTER REVIEW OF THE MEDICAL RECORDS IT WAS DISCOVERED THE PATIENT HAD A HEMI HIP. THE CERAMIC HEAD IS NOW BEING ADDED TO THE COMPLAINT, AS IT CANNOT BE EXCLUDED AS THE CAUSE OF PAIN. THERE IS NO NEW ADDITIONAL INFORMATION THAT WOULD AFFECT THE EXISTING MDR DECISION. THE COMPLAINT WAS UPDATED ON: (B)(4) 2014.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
410313 SELF CENT HIP 52X28 BLU HIP OTHER IMPLANT KWY DEPUY ORTHOPAEDICS, INC. FE9LF1

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention